China Jo-Jo Drugstores, Inc. (CJJD) financial statements (2021 and earlier)

Company profile

Business Address HAI WAI HAI TONGXIN MANSION FLOOR 6
ZHEJIANG PROVINCE, 310008
State of Incorp. NV
Fiscal Year End March 31
SIC 5912 - Drug Stores and Proprietary Stores (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12169151875
Cash and cash equivalents12169151874
Short-term investments   0001
Restricted cash and investments131515169149
Receivables1715131111911
Inventory, net of allowances, customer advances and progress billings15121413101111
Inventory15121413101111
Prepaid expense      2
Advances on inventory purchases5123645
Other current assets2222222
Other undisclosed current assets000000(2)
Total current assets:63615662564742
Noncurrent Assets
Operating lease, right-of-use asset2122
Property, plant and equipment78  4 7
Long-term investments and receivables4300 0 
Long-term investments4300 0 
Intangible assets, net (including goodwill), including:4344 33
Intangible assets, net (excluding goodwill)4344 3 
Other undisclosed intangible assets, net (including goodwill)      3
Deposits noncurrent assets2123 23
Other noncurrent assets1111733
Other undisclosed noncurrent assets1111 22
Total noncurrent assets:393989111017
Other undisclosed assets  93 6 
TOTAL ASSETS:1031007374676260
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities22252426211820
Accounts payable21242325191719
Accrued liabilities1111111
Taxes payable1000100
Debt31312619131816
Due to related parties1011223
Customer advances and deposits4334
Other undisclosed current liabilities214422 
Total current liabilities:56575555404242
Noncurrent Liabilities
Long-term debt and lease obligation2123     
Long-term debt, excluding current maturities34     
Operating lease, liability1819
Liabilities, other than long-term debt  00010
Derivative instruments and hedges, liabilities  00010
Other undisclosed noncurrent liabilities(18)00    
Total noncurrent liabilities:212310010
Total liabilities:76815655414342
Stockholders' equity
Stockholders' equity attributable to parent, including:28211819271917
Common stock0000000
Additional paid in capital68544544372219
Accumulated other comprehensive income4134134
Accumulated deficit(44)(36)(31)(30)(13)(7)(6)
Other undisclosed stockholders' equity attributable to parent111111 
Stockholders' equity attributable to noncontrolling interest(2)(2)(1)   0
Total stockholders' equity:26191719271917
TOTAL LIABILITIES AND EQUITY:1031007374676260

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenues13411710896818977
Revenue, net96818977
Cost of revenue
(Cost of Goods and Services Sold)
(104)(92)(82)(76)(65)(72)(64)
Gross profit:30262520171812
Operating expenses(41)(33)(26)(38)(21)(18)(11)
Operating income (loss):(11)(7)(1)(18)(4)(0)2
Nonoperating income1101110
Investment income, nonoperating210111(0)
Other nonoperating income (expense)(0)(0)(0)00(0)0
Interest and debt expense(0)(1)  (0)  
Other undisclosed loss from continuing operations before equity method investments, income taxes(1)      
Income (loss) from continuing operations before equity method investments, income taxes:(11)(7)(1)(17)(3)12
Other undisclosed income (loss) from continuing operations before income taxes00(0) (2) (1)
Income (loss) from continuing operations before income taxes:(10)(6)(1)(17)(6)11
Income tax expense (benefit)0(0)(0)(0)(0)(0)(0)
Income (loss) from continuing operations:(10)(6)(1)(17)(6)01
Income from discontinued operations0      
Income (loss) before gain (loss) on sale of properties:(10)(6)(1)(17)(6)01
Other undisclosed net loss(0)      
Net income (loss):(10)(6)(1)(17)(6)01
Net income attributable to noncontrolling interest      0
Other undisclosed net income attributable to parent11     
Net income (loss) available to common stockholders, diluted:(9)(6)(1)(17)(6)01

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net income (loss):(10)(6)(1)(17)(6)01
Other undisclosed comprehensive income (loss)     (1)0
Comprehensive income (loss):(10)(6)(1)(17)(6)(1)1
Comprehensive loss, net of tax, attributable to noncontrolling interest      (0)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent2(1)(1)2(2)  
Comprehensive income (loss), net of tax, attributable to parent:(8)(8)(2)(15)(7)(1)1

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: